Wednesday, June 5, 2:00 PM — 3:00 PM EDT
Register Now to View On Demand!
Independent laboratories continue to consolidate into larger national laboratories due to inequities in the clinical lab fee schedule that drive the payment methodology for laboratory services today. This, coupled with increasing staffing challenges, further impacts the availability of timely diagnostics in support of patient care. Lab consolidation pushes those clinical answers out of the state and out of range for time to diagnose. Staff shortages create difficulty in collecting specimens which further impacts costs and turnaround times for diagnosis.
As a result, laboratories are exploring strategic, deliberate partnerships that improve access to quality diagnostic laboratory services, support more timely answers to advance patient care, and are a defense mechanism against acquisition, protecting the clinical laboratory and the value it brings to health care and to patients.
In this session, Steve Serota, CEO of Atalan, Robin Divine, president and CEO of TriCore, and Eric Carbonneau, chief operating officer of TriCore, will share ideas on best practices for laboratories exploring partnerships to ensure they remain competitive, eliminate excess capacity, reduce costs, and improve profit.
Key takeaways:
- How clinical laboratories can collaborate to collectively bring disparate assets and intelligence to foster innovation and investment within a larger healthcare ecosystem
- How laboratories can assess their worth to bring a strong value proposition to a partnership
- The principles and opportunities laboratories should look for in a mission-aligned partnership that can empower them
- What challenges and red flags laboratories should avoid when reviewing partnerships
Speakers:
Steve Serota
Chief Executive Officer
Atalan
Robin Divine
President and CEO
TriCore
Eric Carbonneau
Chief Operating Officer
TriCore
Note: You only need to register once to be signed up for all of the June 2024 Lab Institute talks.